Becker's Healthcare February 10, 2025
Patients aren’t the only ones turning to obesity drugs to manage health. More physicians are using GLP-1s too, The New York Times reported Feb. 10.
While there are no studies documenting the number of physicians taking GLP-1s, a number of physicians told the Times that they’ve noticed many colleagues growing thinner and sharing similar eating habits.
Physicians “are a good litmus test for drugs that are highly effective,” Robert Califf, MD, the former FDA chief, told the Times.
The increased use of drugs like Wegovy and Zepbound is reminiscent of increased statin use among physicians when those drugs first came out. Back then, cardiologists were among the first to take the drugs in...